Literature DB >> 4016738

Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases.

G J Hammons, F P Guengerich, C C Weis, F A Beland, F F Kadlubar.   

Abstract

Hepatic N-oxidation and aryl ring oxidation are generally regarded as critical activation and detoxification pathways for arylamine carcinogenesis. In this study, we examined the in vitro hepatic metabolism of the carcinogens, 2-aminofluorene (2-AF) and 2-naphthylamine (2-NA), and the suspected carcinogen, 1-naphthylamine (1-NA), using high-pressure liquid chromatography. Hepatic microsomes from rats, dogs, and humans were shown to catalyze the N-oxidation of 2-AF and of 2-NA, but not of 1-NA; and the rates of 2-AF N-oxidation were 2- to 3-fold greater than the rates of 2-NA N-oxidation. In each species, rates of 1-hydroxylation of 2-NA and 2-hydroxylation of 1-NA were comparable and were 2- to 5-fold greater than 6-hydroxylation of 2-NA or 5- and 7-hydroxylation of 2-AF. Purified rat hepatic monooxygenases, cytochromes P-450UT-A, P-450UT-H, P-450PB-B, P-450PB-D, P-450BNF-B, and P-450ISF/BNF-G but not P-450PB-C or P-450PB/PCN-E, catalyzed several ring oxidations as well as the N-oxidation of 2-AF. Cytochromes P-450PB-B, P-450BNF-B, and P-450ISF/BNF-G were most active; however, only cytochrome P-450ISF/BNF-G, the isosafrole-induced isozyme, catalyzed the N-oxidation of 2-NA. The purified porcine hepatic flavin-containing monooxygenase, which was known to carry out the N-oxidation of 2-AF, was found to catalyze only ring oxidation of 1-NA and 2-NA. No activity for 1-NA N-oxidation was found with any of the purified enzymes. These data support the hypothesis that 1-NA is probably not carcinogenic. Furthermore, carcinogenic arylamines appear to be metabolized similarly in humans and experimental animals and perhaps selectively by a specific form of hepatic cytochrome P-450. Enzyme mechanisms accounting for the observed product distributions were evaluated by Hückel molecular orbital calculations on neutral, free radical, and cation intermediates. A reaction pathway is proposed that involves two consecutive one-electron oxidations to form a paired substrate cation-enzyme hydroxyl anion intermediate that collapses to ring and N-hydroxy products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016738

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Response to: "Prediction of Voriconazole Non-Linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach".

Authors:  Nicole R Zane; Dhiren R Thakker
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

3.  Species variation in bladder cell and liver cell activation of acetylaminofluorene.

Authors:  R Langenbach; K Rudo; S Ellis; C Hix; S Nesnow
Journal:  Cell Biol Toxicol       Date:  1987-09       Impact factor: 6.691

Review 4.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

5.  The use of computers in the safety evaluation of drugs and other chemicals.

Authors:  C Ioannides; D F Lewis; D V Parke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

Review 6.  The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response.

Authors:  Em Sutrisna
Journal:  J Clin Diagn Res       Date:  2016-11-01

7.  Evaluation of electrochemiluminescent metabolic toxicity screening arrays using a multiple compound set.

Authors:  Shenmin Pan; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2011-03-11       Impact factor: 6.986

Review 8.  Monocyclic aromatic amines as potential human carcinogens: old is new again.

Authors:  Paul L Skipper; Min Young Kim; H-L Patty Sun; Gerald N Wogan; Steven R Tannenbaum
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

Review 9.  Molecular dosimetry of aromatic amines in human populations.

Authors:  P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

10.  Formation and persistence of arylamine DNA adducts in vivo.

Authors:  F A Beland; F F Kadlubar
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.